Skip to main content
SAREUM HOLDINGS PLC logo

SAREUM HOLDINGS PLC — Investor Relations & Filings

Ticker · SAR ISIN · GB00BMC3RJ87 LEI · 213800PKERN2DY8FFM72 IL Manufacturing
Open in API
Filings indexed 348 across all filing types
Latest filing 2023-12-31 Regulatory Filings
Country GB United Kingdom
Listing IL SAR

About SAREUM HOLDINGS PLC

https://www.sareum.com/

Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2023-06-30
Regulatory Filings
2023-12-31 English
Results of AGM
AGM Information Classification · 99% confidence The document explicitly states, 'Sareum Holdings PLC... held its Annual General Meeting ("AGM") today and all resolutions were duly passed.' It then provides a detailed table showing the 'proxy voting results' for various resolutions, including receiving financial statements, re-electing directors, and auditor appointments. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the classification is AGM-R (AGM Information). The document is short and is an announcement of the results, not the full AGM presentation itself, but AGM-R is the most specific category for this content.
2023-12-14 English
Annual General Meeting Statement
AGM Information Classification · 98% confidence The document is explicitly titled 'Annual General Meeting Statement' and states that the company is publishing an update ahead of its 'Annual General Meeting ("AGM") taking place today'. It details operational progress and pipeline updates intended for presentation at the AGM. This content directly aligns with the definition of AGM Information (AGM-R). Although it contains operational updates, the context is explicitly tied to the meeting itself, making AGM-R the most precise classification over ER or IR.
2023-12-14 English
Drawdown of Equity Prepayment Facility
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is clearly an announcement from 'Sareum Holdings PLC' dated November 23, 2023. The content details a 'Drawdown of Equity Prepayment Facility' and the subsequent issuance of warrants. This is a specific corporate action related to financing and capital structure, but it is disseminated via the RNS system, which is the primary mechanism for regulatory announcements on the London Stock Exchange. Since the core event is a financing/capital structure update (drawing down a facility and issuing warrants), the most specific category is 'Capital/Financing Update' (CAP). However, because the document is a standard, short regulatory news service announcement (RNS) detailing a specific corporate event, and 'CAP' is for the update itself, we must check if 'CAP' or 'RNS' is more appropriate. Given the structure (RNS Number, standard boilerplate footer about RNS/LSE), this is fundamentally a regulatory news service release. While it contains capital information, the format strongly suggests a general regulatory filing/announcement. Since the event is a financing/capital change, CAP is highly relevant. Let's re-evaluate the definitions: 'CAP' is for updates on fundraising/financing. 'RNS' is the fallback for miscellaneous filings. Since this is a specific financing event, CAP is the best fit over the general RNS fallback, unless the document is merely announcing the *publication* of a financing document (which it is not; it *is* the announcement). Therefore, CAP is the most precise classification for the content described.
2023-11-23 English
Notice of AGM, Annual Report and Accounts
Regulatory Filings Classification · 98% confidence The document is a short announcement (4630 characters) released via RNS (London Stock Exchange news service). The title explicitly states 'Notice of AGM, Annual Report and Accounts'. The text details the date and location of the Annual General Meeting (AGM) and confirms that the Notice of AGM and the Annual Report and Accounts for the year ended 30 June 2023 will be posted/made available today. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document announces the publication of a report (like the Annual Report) rather than containing the full report itself, it should be classified as a Report Publication Announcement (RPA). Since this document serves primarily to announce the AGM details and the availability of the AGM Notice and the Annual Report, RPA is the most appropriate classification, even though it mentions AGM details (AGM-R) and the Annual Report (10-K). The primary action described is the publication/posting of these documents.
2023-11-21 English
Initiation of food effects study for SDC-1801
Legal Proceedings Report Classification · 99% confidence The document is a press release issued via RNS (Regulatory News Service) on November 9, 2023, announcing a clinical trial update for the drug SDC-1801. It details the initiation of the food effects study within the ongoing Phase 1a trial. This type of announcement, which provides operational and clinical progress updates rather than full financial statements (like 10-K or IR) or management changes (MANG), typically falls under general regulatory announcements or investor relations updates. Since it is a specific operational update disseminated through the RNS system, and it doesn't fit the definitions for ER (Earnings Release), IR (Interim Report), or LTR (Legal Proceedings), the most appropriate classification is RNS (Regulatory Filings) as a general regulatory announcement, or potentially IP (Investor Presentation) if it were a presentation, but it reads like a news release. Given the context of RNS distribution and the nature of the update, RNS is the best fit as a general regulatory filing/announcement.
2023-11-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.